Gossamer Bio, Inc.
GOSS
$0.16
-$0.01-3.38%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -46.66M | -47.24M | -48.22M | -38.27M | -36.64M |
| Total Depreciation and Amortization | 232.00K | 227.00K | 220.00K | 213.00K | 342.00K |
| Total Amortization of Deferred Charges | 255.00K | 251.00K | 248.00K | 245.00K | 241.00K |
| Total Other Non-Cash Items | 5.64M | 1.81M | 8.56M | 642.00K | -262.00K |
| Change in Net Operating Assets | 1.81M | -3.36M | 3.03M | -9.89M | -3.41M |
| Cash from Operations | -38.72M | -48.31M | -36.17M | -47.06M | -39.72M |
| Capital Expenditure | -- | 0.00 | 0.00 | -53.00K | -26.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 41.61M | 73.16M | 17.01M | 44.18M | 22.09M |
| Cash from Investing | 41.61M | 73.16M | 17.01M | 44.13M | 22.06M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 512.00K | 3.96M | 1.87M | 94.00K | 504.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 512.00K | 3.96M | 1.87M | 94.00K | 504.00K |
| Foreign Exchange rate Adjustments | -101.00K | 2.00K | -95.00K | 129.00K | 105.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.30M | 28.80M | -17.38M | -2.71M | -17.05M |